β cell dysfunction during aging: Studies on the role of p21 in the regulation of the Unfolded Protein Response
β cell dysfunction during aging: Studies on the role of p21 in the regulation of the Unfolded Protein Response
批准号:
9178859
负责人:
Hippokratis Kiaris
金额:
$7.33万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-08-01 至 2018-04-30
关键词:
AffectAgeAge FactorsAgingApoptosisApoptoticBeta CellBiochemicalCDKN1A geneCaspaseCell CycleCell SurvivalCell physiologyCellsCessation of lifeDataDiabetes MellitusDiseaseElderlyEndoplasmic ReticulumFemaleFunctional disorderFundingGenderGeneticGenotypeGlucoseHomeostasisInsulinIslets of LangerhansLaboratoriesLifeLinkMeasurementModelingMonitorMusNon-Insulin-Dependent Diabetes MellitusObesityOrganPancreasPathogenesisPathologyPilot ProjectsPopulationPrevalenceProteinsRegulationReportingResolutionRoleSeriesSignal TransductionStructure of beta Cell of isletTP53 geneTestingTissuesTunicamycinValidationage relatedanti agingbasebiological adaptation to stresscell injuryclinically relevantendoplasmic reticulum stressisletmalemouse modelnervous system disorderoncoprotein p21operationpancreatic islet functionprotective effectresearch studyresponsetranscription factor CHOP
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The progressive loss of certain cell populations that compromises tissue and organ function represents
a common feature of age-associated diseases such as diabetes. Endoplasmic reticulum (ER) stress has been
associated to this progressive cell loss of β cells in diabetes that occurs during aging. ER stress is induced
when various intrinsic or extrinsic factors cause the accumulation of misfolded and unfolded proteins in the ER
generating conditions that are unfavorable for the cells’ survival and function. Resolution of ER stress is
attained by the initiation of a prosurvival adaptive biochemical cascade, designated as the unfolded protein
response (UPR), which aims to restore tissue homeostasis. When however ER stress is prolonged or severe,
pro-apoptotic signals associated with the UPR predominate eliminating the damaged cells and compromising
tissue and organ function which prevails during aging. In type 2 diabetes in particular, UPR progressively
causes beta cell apoptosis and ultimately, pancreatic dysfunction contributing to the pathogenesis of age-
associated diabetes.
It is conceivable that the identification of modulators for the UPR, and particularly those capable of re-
enforcing its pro-survival as opposed to its pro-apoptotic activity, may be of particular benefit in aging-
associated conditions. Our laboratory discovered that the cell cycle regulator p21 represents such a modulator
that is capable of inhibiting the pro-apoptotic activity of the UPR. In the present study we propose to evaluate
the induction of ER stress, and the regulatory role of p21 in relation to aging. By using pancreatic islets isolated
from young and old mice as a model we will assess how UPR is induced in relation to age and how it affects
islets’ function and survival. For our studies islets from wild type, p21-deficient, p53-deficient and CHOP-
deficient mice will be used. Our specific aims are: 1. To monitor the profile of p21 expression and UPR
induction in islets in response to ER stress at different ages. 2. To explore if pharmacological and genetic
modulation of p21 expression affects the survival and function of pancreatic islets in association with age
during ER stress. Both male and female mice will be included in our analyses since gender-specific differences
may be linked to distinct UPR-related responses. It is conceivable that our findings will illuminate the operation
of a biologically important and clinically relevant link between p21, ER stress and aging and may find
application in the management of age-associated diabetes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Supplement for Peptide Synthesizer
-
批准号:10799004
-
项目类别:
-
资助金额:$20.6万
-
财政年份:2014
-
负责人:Hippokratis Kiaris
-
依托单位:
Center for Targeted Therapeutics 2
-
批准号:10853524
-
项目类别:
-
资助金额:$106.39万
-
财政年份:2014
-
负责人:Hippokratis Kiaris
-
依托单位:
Targeting NMDA Receptors and Brain Estradiol to Rescue Memory in Aging Females
-
批准号:10726257
-
项目类别:
-
资助金额:$29.8万
-
财政年份:2014
-
负责人:Hippokratis Kiaris
-
依托单位:
Center for Targeted Therapeutics
-
批准号:10403528
-
项目类别:
-
资助金额:$223.5万
-
财政年份:2014
-
负责人:Hippokratis Kiaris
-
依托单位:
Center for Targeted Therapeutics
-
批准号:10624905
-
项目类别:
-
资助金额:$223.5万
-
财政年份:2014
-
负责人:Hippokratis Kiaris
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: